Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.
Typo, here it is...
"Genedrive are thrilled to announce our new partnership with Babirus, the exclusive distributor for the Genedrive MT-RNR1 ID Kit in the UAE!"
"Genedrive are thrilled to announce our new partnership with Babirus, the exclusive distributor for the Genedrive MT-RNR1 ID Kit in the UAEGenedrive are thrilled to announce our new partnership with Babirus, the exclusive distributor for the Genedrive MT-RNR1 ID Kit in the UAE!"
Yes quite positive and there's been a whole load of improvements to the device in the past 4 years. When you start digging through LinkedIn and on the web you see there's a vast amount of media, praise and publicity around the test... it's clear the team and industry have been working very hard to push it forward.
They’ve recently published the views of nurses involved in the PALOH study. Carried out in 2020 though only just published.
https://lnkd.in/eurjQyme
World Hearing Day 3rd March.
End of March usually.
We should have the KSS rollout announcement before then and I hope FDA partner news.
Buys showing as sells now, moving up slightly :)
Nissan, there hasn't been much buying pressure as a lot of the apparent buys have been sells... it's fairly even at the moment with reasonable support around this price.
And this...
Marketing in Saudi Arabia...
https://www.ii-sa.com/medical-devices-solutions
They haven't sent the samples off yet, Lorna said they will do that but it's not something they are waiting on. She said they are evaluating what they have in terms of flows and logs, it's early days and the next steps will involve more drilling.
I believe they’ll pursue NICE full approval whether they get special commissioning or not, as they are such a globally well known and respected organisation.
It won’t take 3 years though. NICE say that they can ask for up to 3 years of evidence generation (for anything not specific to genedrive). However James Cheek made said in the video presentation that they believe they can generate the data NICE have asked for in 3 or 4 months (I need to double check the exact wording but it was around the period of time of a few months).
The recent update to it could be as small as correcting a grammar mistake or editing the meta data.
I believe it’s the comments and responses from the public consultation that happened before NICE announced their ‘recommended’ decision last year.
Will do System!
Guy, the number of sites was mentioned in the Q and A. The locations we don’t know except for Kent, Sussex, Surrey. Also at least one overseas hospital was expected to be up and running this year.
Special commissioning is what I want an update on as that should enable many more to adopt the test without waiting for NICE.
Cheek said they can gather the data required for NICE in around 3 months, so if that starts in October we could have full approval at the end of the year.
And further roll out, there are quite a few sites expected to go live this year… several in Q1.
Yes it’s concerning. I’m going to rewatch the presentation later, specifically the bits about special commissioning.
Well there was a comment from a medical professional on LinkedIn claiming AIHL was being rolled out to Kent Surrey and Sussex in Q1, so if that’s still on then there should be very positive news quite soon.
Need an update on special commissioning after James stated he had 100% clarity that it’s going to happen and will circumvent NICE.
It would be interesting to know at what point and where it was subjected to over 40C. I get the impression it happened in transport or storage before it reached the hospital.
Who knows, hopefully loads more will be revealed on the next update.
I read £50m will be needed to develop this to commercial stage. If they do a JV that will surely involve issuing a large number of shares to the partner. Lorna herself said it’s early days. Would be good to have a roadmap outlined.